Given that AD is frequently accompanied by an increase in type 2 inflammation, which affects p63 levels [49, 50], the clinical phenotype observed in AD reflects the combined effects of keratinocyte-intrinsic changes and immune-related influences and may therefore differ from our observations in HSEs that only reflect keratinocyte-intrinsic changes. The gene discussed is TP63; the disease is Alzheimer disease.